Table 4.

Changes of diurnal CDI parameters in different groups.

Patient groups	CDI parameter	Latanoprost baseline Mean (SD)	Dorzolamide add-on Mean (SD)	Timolol add-on Mean (SD)
Age <65 years	OA RI	0.79 (0.05)	0.76 (0.09)	0.77 (0.07)
	CRA RI	0.68 (0.07)	0.67 (0.07)	0.69 (0.07)
	tSPCA RI	0.57 (0.07)	0.56 (0.09)	0.55 (0.08)
	nSPCA RI	0.56 (0.08)	0.55 (0.09)	0.56 (0.09)
Age ≥65 years	OA RI	0.78 (0.04)	0.79 (0.05)	0.80 (0.04)
	CRA RI	0.72 (0.04)	0.73 (0.06)	0.71 (0.06)
	tSPCA RI	0.59 (0.05)	0.59 (0.05)	0.61 (0.06)
	nSPCA RI	0.58 (0.06)	0.57 (0.08)	0.58 (0.09)
Glaucoma treatment <5 years	OA RI CRA RI	0.77 (0.04) 0.67 (0.06)	0.76 (0.07) 0.66 (0.06)	0.77 (0.07) 0.68 (0.07)
	tSPCA RI	0.56 (0.05)	0.54 (0.07)	0.56 (0.08)
	nSPCA RI	0.55 (0.05)	0.52 (0.07)	0.55 (0.08)
Glaucoma treatment ≥5 years	OA RI	0.79 (0.05)	0.80 (0.07)	0.81 (0.05)
	CRA
	CRA RI	0.73 (0.04)	0.73 (0.05)	0.73 (0.04)
	tSPCA RI	0.60 (0.06)	0.60 (0.06)	0.59 (0.07)
	nSPCA RI	0.59 (0.08)	0.60 (0.08)	0.59 (0.09)
Taken systemic medication <2	OA RI	0.78 (0.05)	0.76 (0.08)	0.78 (0.07)
	CRA RI	0.69 (0.06)	0.68 (0.06)	0.69 (0.06)
	tSPCA RI	0.57 (0.05)	0.56 (0.06)	0.58 (0.06)
	nSPCA RI	0.56 (0.06)	0.56 (0.08)	0.57 (0.09)
Taken systemic medication ≥2	OA RI	0.79 (0.04)	0.79 (0.06)	0.79 (0.06)
	CRA RI	0.71 (0.06)	0.71 (0.07)	0.72 (0.07)
	tSPCA RI	0.59 (0.06)	0.58 (0.09)	0.58 (0.06)
	nSPCA RI	0.58 (0.08)	0.57 (0.09)	0.57 (0.07)